News
Media
Conferences
CME/CE
Partners
Publications
Resources
Subscribe

Global Approaches to the Management of Relapsing Multiple Sclerosis

EP. 1: Diagnosis of Multiple Sclerosis: The McDonald Criteria

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

EP. 2: Differential Diagnosis of Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

EP. 3: MOG-IgG in Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

EP. 4: Clinically Isolated Syndrome Versus Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

EP. 5: First-Line Therapies for Relapsing Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

EP. 6: The Use of Interferon in Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

EP. 7: The Use of Glatiramer Acetate in Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

EP. 8: Clinical Trials for Cladribine in Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

EP. 9: Treating With Cladribine in Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

EP. 10: Role of Siponimod in Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

EP. 11: Ocrelizumab for the Treatment of Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

EP. 12: Role of Ocrelizumab in Europe for Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

EP. 13: Role of Diroximel Fumarate in Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

EP. 14: Role of Ozanimod in Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

EP. 15: Switching Therapies in Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

EP. 16: Decision-Making Process for Treating Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

EP. 17: The Future of Treating Multiple Sclerosis

BySven Meuth, MD, PhD,Patricia Coyle, MD,Wallace Brownlee, MBChB, PhD, FRACP,Fred D. Lublin, MD

September 3rd 2020

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

2026 Rachel Horne Prize Winner Sandra Vukusic, MD, PhD, on Advancing Women's Health in MS

FDA Accepts Fenebrutinib NDA Under Priority Review for Relapsing and Primary Progressive MS

Givinostat Data Point to Delayed Loss of Ambulation, Preserved Muscle Tissue in DMD

Trappsol Cyclo Misses Primary End Point in Phase 3 Trial for Niemann-Pick Disease Type C

Phase 4 Study Evaluates Transition From IVIG to Subcutaneous Efgartigimod in CIDP